AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 280: E918-E927, 2001;
0193-1849/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coker, R. H.
Right arrow Articles by Kjær, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coker, R. H.
Right arrow Articles by Kjær, M.
Vol. 280, Issue 6, E918-E927, June 2001

Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component

Robert H. Coker1, Lene Simonsen3, Jens Bülow3, David H. Wasserman2, and Michael Kjær4

1 Division of Exercise Science, University of Mississippi, University, Mississippi 38677; 2 Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and 3 Department of Clinical Physiology and 4 Sports Medicine Research Unit, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark

To determine the importance of basal glucagon to the stimulation of net splanchnic glucose output (NSGO) during exercise, seven healthy males performed cycle exercise during a pancreatic islet cell clamp. In one group (BG), glucagon was replaced at basal levels and insulin was adjusted to achieve euglycemia. In another group (GD), only insulin was replaced at the identical rate used in BG, and basal glucagon was not replaced. Exogenous glucose infusion was necessary to maintain euglycemia during exercise in BG and during rest and exercise in GD. Arterial glucagon was at least twofold greater in BG than in GD throughout the pancreatic islet cell clamp. Although basal NSGO remained stable in BG (2.5 ± 0.5 mg · kg-1 · min-1), basal NSGO dropped by 70% in GD (0.7 ± 0.3 mg · kg-1 · min-1). NSGO was also greater in BG than in GD at 10 min of moderate exercise, most likely due to the residual effect of basal glucagon replacement. However, NSGO increased slightly and remained similar throughout the remainder of moderate and heavy exercise in BG and GD. Therefore, a mechanism independent of changes in pancreatic hormones and/or the level of glycemia contributes toward modest stimulation of NSGO during moderate and heavy exercise.

islet cell clamp; hormone replacement


This article has been cited by other articles:


Home page
 DiabetesHome page
M. A. Febbraio, N. Hiscock, M. Sacchetti, C. P. Fischer, and B. K. Pedersen
Interleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction
Diabetes, July 1, 2004; 53(7): 1643 - 1648.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. A. FEBBRAIO and B. K. PEDERSEN
Muscle-derived interleukin-6: mechanisms for activation and possible biological roles
FASEB J, September 1, 2002; 16(11): 1335 - 1347.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. Steensberg, M. A Febbraio, T. Osada, P. Schjerling, G. van Hall, B. Saltin, and B. K. Pedersen
Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content
J. Physiol., December 1, 2001; 537(2): 633 - 639.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online